Literature DB >> 11255732

Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.

M R Jeng1, J Feusner.   

Abstract

A boy with acute lymphoblastic leukemia (ALL) experienced life-threatening vincristine neurotoxicity while simultaneously exposed to itraconazole. Five pediatric and six adult cases of itraconazole-enhanced vincristine toxicity have been reported, all with ALL. Upon cessation of the itraconazole, the patient's symptoms resolved, which is similar to the outcome of the previously reported cases: 10 of 11 patients had complete resolution of symptoms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255732     DOI: 10.1080/088800101300002973

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

Review 1.  Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.

Authors:  Brad Moriyama; Stacey A Henning; Janice Leung; Oluwaseun Falade-Nwulia; Paul Jarosinski; Scott R Penzak; Thomas J Walsh
Journal:  Mycoses       Date:  2011-11-29       Impact factor: 4.377

2.  Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine.

Authors:  Serkan Feyyaz Yalin; Sinan Trabulus; Ayse Serap Yalin; Gulsah Yenidunya Yalin; Seniz Ongoren; Mehmet Riza Altiparmak
Journal:  Int J Clin Pharm       Date:  2013-01-22

3.  Itraconazole associated quadriparesis and edema: a case report.

Authors:  Rangaprasad L Karadi; David Gow; Mark Kellett; David W Denning; Ronan B O'Driscoll
Journal:  J Med Case Rep       Date:  2011-04-09

4.  Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.

Authors:  Lihua Yang; Lihua Yu; Xinxin Chen; Yanqun Hu; Bin Wang
Journal:  Med Sci Monit       Date:  2015-06-07

5.  Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell lymphoma: a case report.

Authors:  Zarka Samoon; Munira Shabbir-Moosajee
Journal:  BMC Res Notes       Date:  2014-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.